Still protected against smallpox? Estimation of the duration of vaccine-induced immunity against smallpox

Epidemiology

Volumn 17, Issue 5, 2006, Pages 576-581

  Nishiura, Hiroshi ^a,b,c   Schwehm, Markus ^a   Eichner, Martin ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HIROSHIMA UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE;

AGE; ARTICLE; DISEASE SEVERITY; EPIDEMIC; HISTORY OF MEDICINE; HUMAN; IMMUNOMODULATION; INCIDENCE; INFECTION PREVENTION; INFECTION RESISTANCE; PRIORITY JOURNAL; PROTECTION; QUALITATIVE ANALYSIS; SMALLPOX; STATISTICAL MODEL; TIME; UNITED KINGDOM;

AGE FACTORS; DEMOGRAPHY; DISEASE OUTBREAKS; EPIDEMIOLOGIC FACTORS; GREAT BRITAIN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; IMMUNITY; IMMUNIZATION PROGRAMS; INCIDENCE; MODELS, BIOLOGICAL; POISSON DISTRIBUTION; SMALLPOX; SMALLPOX VACCINE; TIME FACTORS;

EID: 33747137970     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000229196.41862.c2     Document Type: Article

References (33)

1. Fenner F, Henderson DA, Arita I, et al. Smallpox and Its Eradication. Geneva: World Health Organization; 1988.
2. Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9:1131-1137.
3. Gallwitz S, Schutzbank T, Heberling RL, et al. Smallpox: residual antibody after vaccination. J Clin Microbiol. 2003;41:4068-4070.
4. Amara RR, Nigam P, Sharma S, et al. Long-lived poxvirus immunity, robust CD4 Help, and better persistence of CD4 than CD8 T Cells. J Virol. 2004;78:3811-3816.
5. Gayton W. The Value of Vaccination as Shown by an Analysis of 10,403 Cases of Smallpox. London: Gillett & Henty; 1885.
6. Eichner M. Analysis of historical data suggests long-lasting protective effects of smallpox vaccination. Am J Epidemiol. 2003;158:717-723.
7. Arita I. Duration of immunity after smallpox vaccination: a study on vaccination policy against smallpox bioterrorism in Japan. Jpn J Infect Dis. 2002;55:112-116.
8. Eichner M, Dietz K. Transmission potential of smallpox: estimates based on detailed data from an outbreak. Am J Epidemiol. 2003;158:110-117.
9. Gani R, Leach S. Transmission potential of smallpox in contemporary populations. Nature. 2001;414:748-751.
10. Ferguson NM, Keeling MJ, Edmunds WJ, et al. Planning for smallpox outbreaks. Nature. 2003;425:681-685.
11. Barry FW. Report on an Epidemic of Small-Pox at Sheffield, During 1887-88. London: Local Government Board; 1889.
12. Ricketts TF. A classification of cases of smallpox by the numerical severity of the eruption. In: Metropolitan Asylums Board. Reports for the Year 1893 of the Statistical Committee and the Medical Superintendents of the Infectious Hospitals and Imbecile Asylums, Also of the Ambulance and Training Ship 'Exmouth' Committees (8th year of issue). London: McCorquodale; 1894.
13. Hanna W. Studies in Small-Pox and Vaccination. Bristol: John Wright; 1913.
14. Low JS. Report Upon an Epidemic of Small-Pox in the Borough of Dewsbury in 1904. Dewsbury: Joseph Ward; 1905.
15. Chalke HD. Smallpox hospitals - condition as to vaccination of patients suffering from smallpox admitted during 1929. In: Metropolitan Asylums Board. Annual Report for the Year 1929-30 (32nd year of issue). London: Harrison; 1930.
16. Edwardes EJ. Vaccination and Small-Pox in England and Other Countries. London: Churchill; 1892.
17. Hering E. Über Kuhpocken an Kühen [in German]. Stuttgart: Ebner & Seubert; 1839.
18. Dixon CW. Smallpox. London: Churchill; 1962.
19. Marsden JP. A Critical Review of the Clinical Features of 13,686 Cases of Smallpox (variola minor) (Report No. 3209). London: London County Council; 1936 (partly rewrote and reprinted as: Variola minor. A personal analysis of 13,686 cases. Bull Hyg. 1902; 23:735 746.
20. Farrington CP. Modelling forces of infection for measles, mumps and rubella. Stat Med. 1990;9:953-967.
21. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. New York: Oxford University Press; 1991.
22. Johnson NL, Kotz S. Distributions in Statistics: Discrete Distributions. New York: Wiley; 1972.
23. Rao AR. Smallpox. Bombay, India: Kothari Book Department; 1972.
24. Halloran ME, Haber M, Longini IM Jr. Interpretation and estimation of vaccine efficacy under heterogeneity. Am J Epidemiol. 1992;136:328-343.
25. Halloran ME, Struchiner CJ, Longini IM Jr. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol. 1997;146:789-803.
26. Smith PG, Rodrigues LC, Fine PE. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol. 1984;13:87-93.
27. Farrington CP. The measurement and interpretation of age-specific vaccine efficacy. Int J Epidemiol. 1992;21:1014-1020.
28. Slifka MK, Ahmed R. Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol. 1996;4:394-400.
29. Centers for Disease Control and Prevention. Smallpox - Stockholm, Sweden, 1963. MMWR Morb Mortal Wkly Rep. 1963;12:172, 174-176, 183, 188, 191, 220, 236.
30. Mack TM. Smallpox in Europe, 1950-1971. J Infect Dis. 1972;125:161-169.
31. Edghill-Smith Y, Golding H, Manischewitz J, et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med. 2005;11:740-747.
32. Crotty S, Felgner P, Davies H, et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol. 2003;171:4969-4973.
33. el-Ad B, Roth Y, Winder A, et al. The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis. 1992;161:446-448.